Literatur
Krenn V, Morawietz L, Perino G et al (2014) Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract 210(12):779–786
Krenn VT, Liebisch M, Kölbel B et al (2017) CD15 focus score: Infection diagnosis and stratification into low-virulence and high-virulence microbial pathogens in periprosthetic joint infection. Pathol Res Pract 213(5):541–547
Meazza C, Belfiore A, Busico A et al (2016) AKT1 and BRAF mutations in pediatric aggressive fibromatosis. Cancer Med 5(6):1204–1213. https://doi.org/10.1002/cam4.669
Venkataramani V, Küffer S, Kenneth C et al (2018) CD31 expression determines redox status and chemoresistance in human angiosarcomas. Clin Cancer Res 24(2):460–473
Musa J, Aynaud M, Mirabeau O et al (2017) MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis. Cell Death Dis 8(6):22
Casali PG, Abecassis N, Bauer S et al (2018) Soft tissue and visceral sarcomas: ESMO–EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. https://doi.org/10.1093/annonc/mdy096
O’Donnell PW, Griffin AM, Eward WC et al (2014) The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer 120:2866–2875
Trovik C, Skjeldal S, Bauer H et al (2012) Reliability of margin assessment after surgery for extremity soft tissue sarcoma: the SSG experience. Sarcoma. https://doi.org/10.1155/2012/290698
Bhang AA, Beard JAS, Grimmer RF (2004) Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 8(1):1–6
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Scheil-Bertram und E. Wardelmann geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
The supplement containing this article is not sponsored by industry.
Rights and permissions
About this article
Cite this article
Scheil-Bertram, S., Wardelmann, E. Sitzungsbericht der AG Knochen‑, Gelenk- und Weichgewebspathologie. Pathologe 39 (Suppl 2), 333–337 (2018). https://doi.org/10.1007/s00292-018-0499-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-018-0499-6